Global Biosimilar Drug Market Professional Survey Report 2018

Publisher Name :
Date: 13-Jul-2018
No. of pages: 108
Inquire Before Buying

This report studies the global Biosimilar Drug market status and forecast, categorizes the global Biosimilar Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we're using our more than 35 years of biologics experience to develop high-quality biosimilars.

First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.

Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.

Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.

Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.

At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.

The global Biosimilar Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

- Amgen

- Eli Lilly

- Novartis

- CP Guojian Pharma

- Biotech Pharma

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

- North America

- Europe

- China

- Japan

- India

- Southeast Asia

- Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Injection

- Tablets

- Other Types

By Application, the market can be split into

- Ankylosing Spondylitis

- Tumor

- Rheumatoid Arthrtis

- Cardiovascular

- Other Application

The study objectives of this report are:

- To analyze and study the global Biosimilar Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);

- Focuses on the key Biosimilar Drug manufacturers, to study the capacity, production, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilar Drug are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Biosimilar Drug Manufacturers

Biosimilar Drug Distributors/Traders/Wholesalers

Biosimilar Drug Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Biosimilar Drug market, by end-use.

Detailed analysis and profiles of additional market players.

Global Biosimilar Drug Market Professional Survey Report 2018

Table of Contents
Global Biosimilar Drug Market Professional Survey Report 2018
1 Industry Overview of Biosimilar Drug
1.1 Definition and Specifications of Biosimilar Drug
1.1.1 Definition of Biosimilar Drug
1.1.2 Specifications of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.2.1 Injection
1.2.2 Tablets
1.2.3 Other Types
1.3 Applications of Biosimilar Drug
1.3.1 Ankylosing Spondylitis
1.3.2 Tumor
1.3.3 Rheumatoid Arthrtis
1.3.4 Cardiovascular
1.3.5 Other Application
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.3 Manufacturing Process Analysis of Biosimilar Drug
2.4 Industry Chain Structure of Biosimilar Drug
3 Technical Data and Manufacturing Plants Analysis of Biosimilar Drug
3.1 Capacity and Commercial Production Date of Global Biosimilar Drug Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Biosimilar Drug Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Biosimilar Drug Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Biosimilar Drug Major Manufacturers in 2017
4 Global Biosimilar Drug Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Biosimilar Drug Capacity and Growth Rate Analysis
4.2.2 2017 Biosimilar Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Biosimilar Drug Sales and Growth Rate Analysis
4.3.2 2017 Biosimilar Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Biosimilar Drug Sales Price
4.4.2 2017 Biosimilar Drug Sales Price Analysis (Company Segment)
5 Biosimilar Drug Regional Market Analysis
5.1 North America Biosimilar Drug Market Analysis
5.1.1 North America Biosimilar Drug Market Overview
5.1.2 North America 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Biosimilar Drug Sales Price Analysis
5.1.4 North America 2017 Biosimilar Drug Market Share Analysis
5.2 Europe Biosimilar Drug Market Analysis
5.2.1 Europe Biosimilar Drug Market Overview
5.2.2 Europe 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Biosimilar Drug Sales Price Analysis
5.2.4 Europe 2017 Biosimilar Drug Market Share Analysis
5.3 China Biosimilar Drug Market Analysis
5.3.1 China Biosimilar Drug Market Overview
5.3.2 China 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Biosimilar Drug Sales Price Analysis
5.3.4 China 2017 Biosimilar Drug Market Share Analysis
5.4 Japan Biosimilar Drug Market Analysis
5.4.1 Japan Biosimilar Drug Market Overview
5.4.2 Japan 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Biosimilar Drug Sales Price Analysis
5.4.4 Japan 2017 Biosimilar Drug Market Share Analysis
5.5 Southeast Asia Biosimilar Drug Market Analysis
5.5.1 Southeast Asia Biosimilar Drug Market Overview
5.5.2 Southeast Asia 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Biosimilar Drug Sales Price Analysis
5.5.4 Southeast Asia 2017 Biosimilar Drug Market Share Analysis
5.6 India Biosimilar Drug Market Analysis
5.6.1 India Biosimilar Drug Market Overview
5.6.2 India 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Biosimilar Drug Sales Price Analysis
5.6.4 India 2017 Biosimilar Drug Market Share Analysis
6 Global 2013-2018E Biosimilar Drug Segment Market Analysis (by Type)
6.1 Global 2013-2018E Biosimilar Drug Sales by Type
6.2 Different Types of Biosimilar Drug Product Interview Price Analysis
6.3 Different Types of Biosimilar Drug Product Driving Factors Analysis
6.3.1 Injection Growth Driving Factor Analysis
6.3.2 Tablets Growth Driving Factor Analysis
6.3.3 Other Types Growth Driving Factor Analysis
7 Global 2013-2018E Biosimilar Drug Segment Market Analysis (by Application)
7.1 Global 2013-2018E Biosimilar Drug Consumption by Application
7.2 Different Application of Biosimilar Drug Product Interview Price Analysis
7.3 Different Application of Biosimilar Drug Product Driving Factors Analysis
7.3.1 Ankylosing Spondylitis of Biosimilar Drug Growth Driving Factor Analysis
7.3.2 Tumor of Biosimilar Drug Growth Driving Factor Analysis
7.3.3 Rheumatoid Arthrtis of Biosimilar Drug Growth Driving Factor Analysis
7.3.4 Cardiovascular of Biosimilar Drug Growth Driving Factor Analysis
7.3.5 Other Application of Biosimilar Drug Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Biosimilar Drug
8.1 Amgen
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Amgen 2017 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Amgen 2017 Biosimilar Drug Business Region Distribution Analysis
8.2 Eli Lilly
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Eli Lilly 2017 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Eli Lilly 2017 Biosimilar Drug Business Region Distribution Analysis
8.3 Novartis
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Novartis 2017 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Novartis 2017 Biosimilar Drug Business Region Distribution Analysis
8.4 CP Guojian Pharma
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 CP Guojian Pharma 2017 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 CP Guojian Pharma 2017 Biosimilar Drug Business Region Distribution Analysis
8.5 Biotech Pharma
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Biotech Pharma 2017 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Biotech Pharma 2017 Biosimilar Drug Business Region Distribution Analysis
9 Development Trend of Analysis of Biosimilar Drug Market
9.1 Global Biosimilar Drug Market Trend Analysis
9.1.1 Global 2018-2025 Biosimilar Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Biosimilar Drug Sales Price Forecast
9.2 Biosimilar Drug Regional Market Trend
9.2.1 North America 2018-2025 Biosimilar Drug Consumption Forecast
9.2.2 Europe 2018-2025 Biosimilar Drug Consumption Forecast
9.2.3 China 2018-2025 Biosimilar Drug Consumption Forecast
9.2.4 Japan 2018-2025 Biosimilar Drug Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Biosimilar Drug Consumption Forecast
9.2.6 India 2018-2025 Biosimilar Drug Consumption Forecast
9.3 Biosimilar Drug Market Trend (Product Type)
9.4 Biosimilar Drug Market Trend (Application)
10 Biosimilar Drug Marketing Type Analysis
10.1 Biosimilar Drug Regional Marketing Type Analysis
10.2 Biosimilar Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Biosimilar Drug by Region
10.4 Biosimilar Drug Supply Chain Analysis
11 Consumers Analysis of Biosimilar Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Biosimilar Drug Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Biosimilar Drug
Table Product Specifications of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure Global Production Market Share of Biosimilar Drug by Type in 2017
Figure Injection Picture
Table Major Manufacturers of Injection
Figure Tablets Picture
Table Major Manufacturers of Tablets
Figure Other Types Picture
Table Major Manufacturers of Other Types
Table Applications of Biosimilar Drug
Figure Global Consumption Volume Market Share of Biosimilar Drug by Application in 2017
Figure Ankylosing Spondylitis Examples
Table Major Consumers in Ankylosing Spondylitis
Figure Tumor Examples
Table Major Consumers in Tumor
Figure Rheumatoid Arthrtis Examples
Table Major Consumers in Rheumatoid Arthrtis
Figure Cardiovascular Examples
Table Major Consumers in Cardiovascular
Figure Other Application Examples
Table Major Consumers in Other Application
Figure Market Share of Biosimilar Drug by Regions
Figure North America Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure Europe Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure China Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure Japan Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure Southeast Asia Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure India Biosimilar Drug Market Size (Million USD) (2013-2025)
Table Biosimilar Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2017
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Industry Chain Structure of Biosimilar Drug
Table Capacity and Commercial Production Date of Global Biosimilar Drug Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Biosimilar Drug Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Biosimilar Drug Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Biosimilar Drug Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Biosimilar Drug 2013-2018E
Figure Global 2013-2018E Biosimilar Drug Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Biosimilar Drug Market Size (Value) and Growth Rate
Table 2013-2018E Global Biosimilar Drug Capacity and Growth Rate
Table 2017 Global Biosimilar Drug Capacity (K DDD) List (Company Segment)
Table 2013-2018E Global Biosimilar Drug Sales (K DDD) and Growth Rate
Table 2017 Global Biosimilar Drug Sales (K DDD) List (Company Segment)
Table 2013-2018E Global Biosimilar Drug Sales Price (USD/DDD)
Table 2017 Global Biosimilar Drug Sales Price (USD/DDD) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K DDD) of Biosimilar Drug 2013-2018E
Figure North America 2013-2018E Biosimilar Drug Sales Price (USD/DDD)
Figure North America 2017 Biosimilar Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K DDD) of Biosimilar Drug 2013-2018E
Figure Europe 2013-2018E Biosimilar Drug Sales Price (USD/DDD)
Figure Europe 2017 Biosimilar Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K DDD) of Biosimilar Drug 2013-2018E
Figure China 2013-2018E Biosimilar Drug Sales Price (USD/DDD)
Figure China 2017 Biosimilar Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K DDD) of Biosimilar Drug 2013-2018E
Figure Japan 2013-2018E Biosimilar Drug Sales Price (USD/DDD)
Figure Japan 2017 Biosimilar Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K DDD) of Biosimilar Drug 2013-2018E
Figure Southeast Asia 2013-2018E Biosimilar Drug Sales Price (USD/DDD)
Figure Southeast Asia 2017 Biosimilar Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K DDD) of Biosimilar Drug 2013-2018E
Figure India 2013-2018E Biosimilar Drug Sales Price (USD/DDD)
Figure India 2017 Biosimilar Drug Sales Market Share
Table Global 2013-2018E Biosimilar Drug Sales (K DDD) by Type
Table Different Types Biosimilar Drug Product Interview Price
Table Global 2013-2018E Biosimilar Drug Sales (K DDD) by Application
Table Different Application Biosimilar Drug Product Interview Price
Table Amgen Information List
Table Product Overview
Table 2017 Amgen Biosimilar Drug Revenue (Million USD), Sales (K DDD), Ex-factory Price (USD/DDD)
Figure 2017 Amgen Biosimilar Drug Business Region Distribution
Table Eli Lilly Information List
Table Product Overview
Table 2017 Eli Lilly Biosimilar Drug Revenue (Million USD), Sales (K DDD), Ex-factory Price (USD/DDD)
Figure 2017 Eli Lilly Biosimilar Drug Business Region Distribution
Table Novartis Information List
Table Product Overview
Table 2017 Novartis Biosimilar Drug Revenue (Million USD), Sales (K DDD), Ex-factory Price (USD/DDD)
Figure 2017 Novartis Biosimilar Drug Business Region Distribution
Table CP Guojian Pharma Information List
Table Product Overview
Table 2017 CP Guojian Pharma Biosimilar Drug Revenue (Million USD), Sales (K DDD), Ex-factory Price (USD/DDD)
Figure 2017 CP Guojian Pharma Biosimilar Drug Business Region Distribution
Table Biotech Pharma Information List
Table Product Overview
Table 2017 Biotech Pharma Biosimilar Drug Revenue (Million USD), Sales (K DDD), Ex-factory Price (USD/DDD)
Figure 2017 Biotech Pharma Biosimilar Drug Business Region Distribution
Figure Global 2018-2025 Biosimilar Drug Market Size (K DDD) and Growth Rate Forecast
Figure Global 2018-2025 Biosimilar Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Biosimilar Drug Sales Price (USD/DDD) Forecast
Figure North America 2018-2025 Biosimilar Drug Consumption Volume (K DDD) and Growth Rate Forecast
Figure China 2018-2025 Biosimilar Drug Consumption Volume (K DDD) and Growth Rate Forecast
Figure Europe 2018-2025 Biosimilar Drug Consumption Volume (K DDD) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Biosimilar Drug Consumption Volume (K DDD) and Growth Rate Forecast
Figure Japan 2018-2025 Biosimilar Drug Consumption Volume (K DDD) and Growth Rate Forecast
Figure India 2018-2025 Biosimilar Drug Consumption Volume (K DDD) and Growth Rate Forecast
Table Global Sales Volume (K DDD) of Biosimilar Drug by Type 2018-2025
Table Global Consumption Volume (K DDD) of Biosimilar Drug by Application 2018-2025
Table Traders or Distributors with Contact Information of Biosimilar Drug by Region
  • Global and Chinese Adalimumab Biosimilar Industry, 2018 Market Research Report
    Published: 08-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Adalimumab Biosimilar Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Adalimumab Biosimilar industry with a focus on the Chinese market. The report provides key statistics on the market status of the Adalimumab Biosimilar manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry i......
  • Global Oncology Biosimilars Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Dec-2018        Price: US 3480 Onwards        Pages: 132
    Oncology biosimilars are similar versions of oncology biologics that are manufactured by different companies and have been officially approved for cancer treatment. Biosimilars are cost-effective molecules with the same efficacy and potency as the original reference biologic. The relatively easy manufacturing of biosimilars and the license to manufacture biosimilars after the expiration of original reference biologic is acting in favor of the global oncology biosimilars market. Sc......
  • Global Adalimumab Biosimilar Market Research Report 2012-2023
    Published: 05-Dec-2018        Price: US 3290 Onwards        Pages: 106
    Summary The global Adalimumab Biosimilar market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned a......
  • Global and Chinese Biosimilar Drug Industry, 2018 Market Research Report
    Published: 02-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Biosimilar Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Biosimilar Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biosimilar Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its defin......
  • Global and Chinese Biosimilar Monoclonal Antibodies Industry, 2018 Market Research Report
    Published: 23-Nov-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Biosimilar Monoclonal Antibodies Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Biosimilar Monoclonal Antibodies industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biosimilar Monoclonal Antibodies manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a......
  • Global Biologics and Biosimilars Market Research Report 2018
    Published: 09-Nov-2018        Price: US 2900 Onwards        Pages: 126
    This report studies the global Biologics and Biosimilars market status and forecast, categorizes the global Biologics and Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Pfizer - Roche - Amgen - AbbVie - Sanofi......
  • Global Oncology Biosimilars Market Research Report 2018
    Published: 05-Nov-2018        Price: US 2900 Onwards        Pages: 119
    This report studies the global Oncology Biosimilars market status and forecast, categorizes the global Oncology Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Celltrion Inc. - Pfizer Inc. - Biocon - BIOCAD - Apote......
  • Global Adalimumab Biosimilar Market Insights, Forecast to 2025
    Published: 05-Nov-2018        Price: US 3900 Onwards        Pages: 119
    This report studies the global market size of Adalimumab Biosimilar in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Adalimumab Biosimilar in these regions. This research report categorizes the global Adalimumab Biosimilar market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market dri......
  • Global Biosimilar Drug Market Insights, Forecast to 2025
    Published: 31-Oct-2018        Price: US 3900 Onwards        Pages: 112
    This report studies the global market size of Biosimilar Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilar Drug in these regions. This research report categorizes the global Biosimilar Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunitie......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs